Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Hema.to
hema.to is a deeptech AI company focused on revolutionizing immune medicine through AI-powered cytometry. Their solutions aim to provide precise diagnostics and optimal treatments tailored to…
Hema.to
hema.to is a deeptech AI company focused on revolutionizing immune medicine through AI-powered cytometry. Their solutions aim to provide precise diagnostics and optimal treatments tailored to…
TL;DR
Headquarters: Munich, Germany
Product focus: AI-powered automated flow cytometry analysis and diagnostic support
Notable traction: Database of >600,000 FCS files; claims >98% mean accuracy in a clinical study
Recent financing: Seed round Feb 2025; €3.6M reported
Company Overview
Problem Domain
Flow cytometry data analysis and diagnostic decision support in hemato-oncology and immunology.
Founded
2021
Industry
Biotechnology
Funding Track Record
€3.6M
Round included Elaia, Heal Capital, HTGF, Bayern Kapital and others
Investor Signal
“Backed by a mix of deeptech/health investors including LUMO labs, Elaia, Heal Capital, HTGF and Bayern Kapital”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week